EASI - The European Autoimmunity Standardisation Initiative: A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 138-144

  Shoenfeld, Yehuda ^a   Cervera, Ricard ^b   Haass, Michael ^c   Kallenberg, Cees ^d   Khamashta, Munther ^e   Meroni, Pierluigi ^f   Piette, Jean Charles ^g   Schmidt, Reinhold ^h   Wiik, Allan ⁱ  

^a SHEBA MEDICAL CENTER   (Israel)

^b HOSPITAL CLÍNIC   (Spain)

^c Thermo Fisher Scientific   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ST THOMAS HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MILAN   (Italy)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ STATENS SERUM INSTITUT   (Denmark)

Author keywords

Autoimmunity; Guidelines; Laboratory diagnostics; Standardization

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; EUROPE; EUROPEAN AUTOIMMUNITY STANDARDIZATION INITIATIVE; HEALTH CARE SYSTEM; HUMAN; IMMUNOASSAY; LABORATORY TEST; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL PROFESSION; ORGANIZATION; RHEUMATIC DISEASE; STANDARDIZATION; ARTICLE; BIOLOGICAL MODEL; IMMUNOLOGY; MEDICAL SOCIETY; PUBLISHING; STANDARD;

AUTOIMMUNE DISEASES; EUROPE; HUMANS; MODELS, IMMUNOLOGICAL; PUBLISHING; RHEUMATIC DISEASES; SOCIETIES, MEDICAL;

EID: 34848892801     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.016     Document Type: Conference Paper

References (11)

1. SHOENFELD, Y., M.E. GERSHWIN & P.L. MERONI. 2006. Eds. Autoantibodies, 2nd ed. Elsevier. Amsterdam.
2. CONRAD, K. & U. SACK. 2002/2003. Eds. Autoantigens, Autoantibodies, Autoimmunity. Papst Science Publishers. Berlin.
3. REICHLIN, M. 1998. Systemic lupus erythematosus. In The Autoimmune Diseases, 3rd ed. N.R. Rose & I.R. Mackay, Eds.: 283-298. Academic Press. New York.
4. GALPERIN, C. & M.E. GERSHWIN. 1998. Systemic sclerosis (scleroderma). In The Autoimmune Diseases, 3rd ed. N.R. Rose & I.R. Mackay. Eds.: 317-342. Academic Press. New York.
5. WIIK, A. 2005. Anti-nuclear antibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand. J. Rheumatol. 34: 260-268.
6. FELTKAMP, T.E., T.B. KIRKWOOD, R.N. MAINI,, et al. 1988. The first international standard for antibodies to double stranded DNA. Ann. Rheum. Dis. 47: 740-746.
7. MCMILLAN, S.A. & A.C. FAY. 1988. Evaluation of five commercial kits to detect dsDNA antibodies. J. Clin. Pathol. 41: 1223-1228.
8. WERLE, E., M. BLAZEK & W. FIEHN. 1992. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Critzhidia luciliae immunofluorescence. Lupus 1: 369-377.
9. RIBOLDI, P., M. GEROSA, G. MORONI, et al. 2005. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity 38: 39-43.
10. WOOD, W.G. & R. HANKE. 2004. Comparability of method results and performance in a national external quality assessment scheme between 1993 and 2003 using thyroid associated antibodies as examples. Clin. Lab. 50: 209-221.
11. TOZZOLI, R., N. BIZZARO & E. TONUTTI. 2002. Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin. Chem. Lab. Med. 40: 566-573.